Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1972 1
1985 1
1987 3
1988 2
1989 3
1990 2
1991 2
1992 2
1995 2
1998 2
1999 1
2001 2
2002 6
2003 3
2004 1
2005 2
2006 5
2007 3
2008 5
2009 7
2010 5
2011 10
2012 7
2013 3
2014 7
2015 3
2016 6
2017 6
2018 8
2019 5
2020 6
2021 5
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. Among authors: galvez f. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Plant NHX cation/proton antiporters.
Rodríguez-Rosales MP, Gálvez FJ, Huertas R, Aranda MN, Baghour M, Cagnac O, Venema K. Rodríguez-Rosales MP, et al. Among authors: galvez fj. Plant Signal Behav. 2009 Apr;4(4):265-76. doi: 10.4161/psb.4.4.7919. Plant Signal Behav. 2009. PMID: 19794841 Free PMC article. Review.
Plant rDNA database: update and new features.
Garcia S, Gálvez F, Gras A, Kovařík A, Garnatje T. Garcia S, et al. Among authors: galvez f. Database (Oxford). 2014 Jun 30;2014:bau063. doi: 10.1093/database/bau063. Print 2014. Database (Oxford). 2014. PMID: 24980131 Free PMC article. Review.
Overvalued ideas: psychopathologic issues.
Santín JM, Gálvez FM. Santín JM, et al. Among authors: galvez fm. Actas Esp Psiquiatr. 2011 Jan-Feb;39(1):70-4. Epub 2011 Jan 1. Actas Esp Psiquiatr. 2011. PMID: 21274824 Free article.
The biotic ligand model: a historical overview.
Paquin PR, Gorsuch JW, Apte S, Batley GE, Bowles KC, Campbell PG, Delos CG, Di Toro DM, Dwyer RL, Galvez F, Gensemer RW, Goss GG, Hostrand C, Janssen CR, McGeer JC, Naddy RB, Playle RC, Santore RC, Schneider U, Stubblefield WA, Wood CM, Wu KB. Paquin PR, et al. Among authors: galvez f. Comp Biochem Physiol C Toxicol Pharmacol. 2002 Sep;133(1-2):3-35. doi: 10.1016/s1532-0456(02)00112-6. Comp Biochem Physiol C Toxicol Pharmacol. 2002. PMID: 12428632 Review.
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study.
Fernández-Serra A, López-Reig R, Márquez R, Gallego A, de Sande LM, Yubero A, Pérez-Segura C, Ramchandani-Vaswani A, Barretina-Ginesta MP, Mendizábal E, Esteban C, Gálvez F, Sánchez-Heras AB, Guerra-Alía EM, Gaba L, Quindós M, Palacio I, Alarcón J, Oaknin A, Aliaga J, Ramírez-Calvo M, García-Casado Z, Romero I, López-Guerrero JA. Fernández-Serra A, et al. Among authors: galvez f. Cancers (Basel). 2023 Jun 1;15(11):3030. doi: 10.3390/cancers15113030. Cancers (Basel). 2023. PMID: 37296992 Free PMC article.
125 results